Position in NTRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,778,932
+$2,439,200 QoQ
Shares Held
72,864
-16.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#153
of 844 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Korea Investment CORP holds $343,476,278 across 12 Diagnostics & Research names. NTRA ranks #3 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
277,446 | $139,100,326 | |
| 2 | DHR |
Danaher Corp /De/
|
415,041 | $79,057,009 | |
| 3 | NTRA |
Natera, Inc.
This page
|
72,864 | $19,778,932 | |
| 4 | WAT |
Waters Corp /De/
|
49,296 | $18,487,971 | |
| 5 | ILMN |
Illumina, Inc.
|
91,843 | $16,148,754 | |
| 6 | A |
Agilent Technologies, Inc.
|
116,190 | $15,433,517 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
72,030 | $13,917,636 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
25,513 | $13,431,063 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,778,932 | 72,864 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $17,339,732 | 86,703 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $10,406,642 | 45,426 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,099,259 | 44,103 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,035,542 | 59,403 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,656,824 | 40,003 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||